AlphaStocks
4.9
Weak

STERIS plc (STE)

As of Sep 20, 2026, STERIS plc (STE) scores 4.9/10 on AlphaStocks' five-model composite, #120 of 168 Health Care stocks. At $205, STE trades 6% above its model fair value of $194.

Health Care / Health Care Equipment

S&P 500

$205.12

Below average on several measures. Research carefully.

Weak

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#120out of 168 in Health Care

Is STERIS plc a Good Investment in 2026?

STERIS plc (STE) scores 4.9 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates STERIS plc as Strong (8/9). The Greenblatt Magic Formula model is the least favorable, rating it Neutral. STERIS plc currently trades 6% above its estimated fair value of $194. STERIS plc ranks #120 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E25.9ROE10.9Market Cap20BDiv Yield1.1

Estimated Fair Value

$194.166% above

Trading slightly above estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

8/9

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

90% above fair value

Lynch

Neutral

PEG 1.2 · Fast Grower

Greenblatt

Neutral

Earnings yield 4.8% · ROC 32%

Frequently Asked Questions

Is STERIS plc (STE) a good investment?
As of Sep 20, 2026, STERIS plc (STE) scores 4.9/10 on AlphaStocks' five-model composite, #120 of 168 Health Care stocks. At $205, STE trades 6% above its model fair value of $194. That score is below average, suggesting caution.
What is STERIS plc's Piotroski F-Score?
STERIS plc's Piotroski F-Score status is Strong. The raw score is 8/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is STE overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $194, STE appears overvalued. The stock currently trades 6% above its estimated fair value. Trading slightly above estimated fair value.
How does STE compare to other Health Care stocks?
STERIS plc ranks #120 out of 168 stocks in the Health Care sector, placing it in the top 71% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about STE?
AlphaStocks evaluates STE using five proven investment models. Piotroski: Strong; Buffett: Attractive; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 4.9/10.

Similar Stocks

INSPUFPTBDX

Compare STE with

INSP vs STESTE vs UFPTBDX vs STE

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer